Zydus Lifesciences starts Phase IV clinical trials for novel drug 'Desidustat' https://ift.tt/Hcn3ub1

Zydus said Desidustat, sold under the Oxemia trademark, is a prescription drug approved in India for patients with CKD induced anemia, and can be taken only under the advice and guidance of a nephrologist or an internal medicine specialist.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GVTzqJH
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.